Chronic Obstructive Pulmonary Disease Virtual Reality Therapy Market Expansion Continues, with Forecast Valuation of $2.79 Billion by 2029

Use code ONLINE20 to get 20% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

Chronic Obstructive Pulmonary Disease Virtual Reality Therapy Market Size Valuation Forecast: What Will the Market Be Worth by 2025?
The market size for virtual reality therapy of chronic obstructive pulmonary disease has experienced swift growth in the recent past. The market is projected to expand from $1.15 billion in 2024 to $1.38 billion in 2025, with a compound annual growth rate (CAGR) of 19.7%. This remarkable growth in the historic period can be traced back to the rising occurrence of chronic obstructive pulmonary disease, an increased demand for non-drug interventions, a surge in the acceptance of digital health solutions, the need for cost-effective rehab alternatives, and the escalating awareness about the benefits of remote therapy.

Chronic Obstructive Pulmonary Disease Virtual Reality Therapy Market Size Forecast: What's the Projected Valuation by 2029?
In the coming years, the market size for virtual reality therapy for chronic obstructive pulmonary disease is anticipated to experience significant growth. The estimated growth projection is an increase to $2.80 billion by 2029 with a compound annual growth rate (CAGR) of 19.3%. This expected growth within the forecast period is due to factors such as the rising acceptance of home-based rehabilitation, extensive expansion of healthcare digitalization and telemedicine, increasing healthcare spending in emergent markets, favourable reimbursement policies for digital therapeutics, and a prioritized focus on reducing hospital re-admissions. Noteworthy trends during the forecast period involve the amalgamation of virtual reality (VR) with artificial intelligence for individualized therapy, the application of cloud-based platforms for distant pulmonary rehabilitation, the inclusion of haptic feedback for in-depth breathing exercises, the utilization of digital twins for respiratory health simulation, and integration with wearable sensors for instantaneous monitoring.

View the full report here:
https://www.thebusinessresearchcompany.com/report/chronic-obstructive-pulmonary-disease-virtual-reality-therapy-global-market-report

What Are the Drivers Transforming the Chronic Obstructive Pulmonary Disease Virtual Reality Therapy Market?
The growth of the chronic obstructive pulmonary disease virtual reality therapy market is anticipated to be propelled by the rising awareness and acceptance of virtual reality therapy. Virtual reality therapy uses immersive technology to create interactive environments for treatment and rehabilitation. Its growth is fueled by its demonstrated efficiency to alleviate pain and anxiety, providing an attractive, non-invasive and drug-free alternative for patients to improve therapy experiences and results. By spreading awareness about virtual reality therapy, its adoption in the treatment of chronic obstructive pulmonary disease (COPD) is promoted, contributing to the knowledge of patients and providers and encouraging the use of digital rehabilitation solutions. This enhances therapy engagement, as users become more acquainted with immersive therapy, which in turn elevates compliance and overall health results. For example, in July 2024, it was reported by the U.S. Department of Veterans Affairs, a US federal government institution, that approximately 3,500 VR headsets had been distributed to over 170 VA medical centers and outpatient clinics. This tripled the availability of the headsets for therapeutic use. The chronic obstructive pulmonary disease virtual reality therapy market is also expected to be driven by the growing focus on personalized medicine, which influences treatments and boosts patient engagement. Personalized medicine tailors prevention and treatment strategies to a person's specific genetic makeup, lifestyle, and environment. The rise in personalized medicine is mostly attributable to genomics advancements, which allow for precise identification of genetic variations and individually tailored treatments. Tailoring immersive rehabilitation programs to individual patient needs through personalized medicine makes therapies more effective and pinpointed in treating chronic obstructive pulmonary disease (COPD). It enhances therapy outcomes by addressing particular symptoms, capabilities, and preferences, boosting patient engagement and adherence. In February 2024, the Personalized Medicine Coalition (PMC), a US-based nonprofit organization, reported that in 2023, the U.S. Food and Drug Administration (FDA) authorized 26 new personalized medicines, a noticeable rise from the 12 approved in 2022.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=28165&type=smp

Which Segments in the Chronic Obstructive Pulmonary Disease Virtual Reality Therapy Market Offer the Most Profit Potential?
The chronic obstructive pulmonary disease virtual reality therapy market covered in this report is segmented as

1) By Component: Hardware, Software, Services
2) By Therapy Type: Immersive Virtual Reality Therapy, Non-Immersive Virtual Reality Therapy
3) By Application: Pulmonary Rehabilitation, Patient Education, Pain Management, Anxiety And Stress Reduction, Other Applications
4) By End-User: Hospitals, Clinics, Homecare Settings, Other End-Users

Subsegments:
1) By Hardware: Virtual Reality Headsets, Motion Sensors, Haptic Feedback Devices, Wearable Monitors
2) By Software: Pulmonary Rehabilitation Applications, Patient Monitoring Platforms, Data Analytics Tools, Therapy Gamification Software
3) By Services: Remote Pulmonary Therapy, Technical Support, Training And Education, System Integration

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=28165&type=smp

Which Firms Dominate the Chronic Obstructive Pulmonary Disease Virtual Reality Therapy Market by Market Share and Revenue in 2025?
Major companies operating in the chronic obstructive pulmonary disease virtual reality therapy market are Inova Health System, Rush University Medical Center, Penumbra Inc., Burke Rehabilitation Hospital, MindMaze SA, XRHealth Inc., Jolly Good Inc., AppliedVR Inc., Carda Health Inc., Lincare Inc., Virtually Better Inc., Wellinks Inc., Breathe Better Rehab, Kivo Health Inc., and VRelax B.V.

Which Regions Offer the Highest Growth Potential in the Chronic Obstructive Pulmonary Disease Virtual Reality Therapy Market?
North America was the largest region in the chronic obstructive pulmonary disease virtual reality therapy market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in chronic obstructive pulmonary disease virtual reality therapy report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=28165

This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 7882 955267,
Asia: +91 88972 63534,
Americas: +1 310-496-7795 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.